[1]
Murat KARKUCAK et al. 2021. Infliximab therapy provides beneficial effects for choroidal thickness increase in patients with active ankylosing spondylitis: A possible mechanism mediating the suppressing of uveitis attacks. Archives of Rheumatology. 36, 1 (Mar. 2021), 056–062. DOI:https://doi.org/10.46497/ArchRheumatol.2021.7806.